InsidersTradesSigma
Follow the Granules share price and the full insider trade history of the company, a listed issuer based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €203.1bn. The latest transaction was disclosed on 27 August 2026 (Disposal). Among the most active insiders: Life Insurance Corporation of India. The full history is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Granules Buy (bullish), based on 7 analysts. Average price target: ₹645.71.
Fundamental score
Ranked 12,341 of 29,062 companies
55.8
score / 100
Value41
Quality71
FCF yld1.2%
Earn yld2.9%
EV/EBITDA18.9x
ROE·
Gross mgn62%
Net mgn11%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 August 2026
Declarations1 total
4,956,124 shares-MarketSEBI:2baf50c8bd9f1a961620dbbb8354e6a0a7663028
1 of 1 declaration
About Granules
Granules is a company listed on the XBOM, specializing in the manufacturing of pharmaceutical products. It focuses on the production of generic drugs and complex formulations.